Comparison of BMIPP-SPECT/CT to¹⁸ FDG-PET/CT for Imaging Brown or Browning Fat in a Preclinical Model

Obesity is a leading cause of preventable death and morbidity. To elucidate the mechanisms connecting metabolically active brown adipose tissue (BAT) and metabolic health may provide insights into methods of treatment for obesity-related conditions.¹⁸ F-fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸ FDG-PET/CT) is traditionally used to image human BAT activity. However, the primary energy source of BAT is derived from intracellular fatty acids and not glucose. Beta-methyl-p-iodophenylpentadecanoic acid (BMIPP) is a fatty acid analogue amenable to in vivo imaging by single photon emission computed tomography/CT (SPECT/CT) when radiolabeled with iodine isotopes. In this study, we compare the use of¹⁸ FDG-PET/CT and¹²⁵ I-BMIPP-SPECT/CT for fat imaging to ascertain whether BMIPP is a more robust candidate for the non-invasive evaluation of metabolically active adipose depots. Interscapular BAT, inguinal white adipose tissue (iWAT), and gonadal white adipose tissue (gWAT) uptake of¹⁸ FDG and¹²⁵ I-BMIPP was quantified in mice following treatment with the BAT-stimulating drug CL-316,243 or saline vehicle control. After CL-316,243 treatment, uptake of both radiotracers increased in BAT and iWAT. The standard uptake value (SUV_mean) for¹⁸ FDG and¹²⁵ I-BMIPP significantly correlated in these depots, although uptake of¹²⁵ I-BMIPP in BAT and iWAT more closely mimicked the fold-change in metabolic rate as measured by an extracellular flux analyzer. Herein, we find that imaging BAT with the radioiodinated fatty acid analogue BMIPP yields more physiologically relevant data than¹⁸ FDG-PET/CT, and its conventional use may be a pivotal tool for evaluating BAT in both mice and humans.